viru
infect
pose
signific
global
health
challeng
especi
view
fact
emerg
resist
viral
strain
advers
side
effect
associ
prolong
use
continu
slow
applic
effect
antivir
therapi
make
imper
need
develop
safe
potent
altern
convent
antivir
drug
present
scenario
nanoscal
materi
emerg
novel
antivir
agent
possibl
offer
uniqu
chemic
physic
properti
silver
nanoparticl
mainli
studi
antimicrobi
potenti
bacteria
also
proven
activ
sever
type
virus
includ
human
imunodefici
viru
hepat
b
viru
herp
simplex
viru
respiratori
syncyti
viru
monkey
pox
viru
use
metal
nanoparticl
provid
interest
opportun
novel
antivir
therapi
sinc
metal
may
attack
broad
rang
target
viru
lower
possibl
develop
resist
compar
convent
antivir
present
review
focus
develop
method
product
silver
nanoparticl
use
antivir
therapeut
pathogen
virus
molecul
virus
repres
one
lead
caus
diseas
death
worldwid
thank
vaccin
programm
numer
diseas
use
kill
mani
perman
disabl
other
erad
smallpox
greatli
reduc
burden
diseas
case
paralyt
diseas
poliomyel
howev
today
press
viral
pathogen
still
vaccin
avail
realiz
huge
econom
impact
sever
viral
diseas
caus
global
commun
need
think
common
cold
influenza
variou
problem
due
herpesvirus
shingl
genit
herp
chickenpox
infecti
mononucleosi
herp
kerat
neonat
dissemin
infect
viral
enceph
virus
also
abl
caus
consider
distress
sometim
persist
infect
may
lead
cancer
acquir
immunodefici
hepat
virus
mainli
hbv
hcv
human
immunodefici
viru
hiv
much
effort
expend
attempt
develop
vaccin
diseas
without
appreci
success
least
virus
name
hcv
hiv
herpesvirus
present
develop
new
vaccin
virus
seem
like
continu
elus
togeth
risk
emerg
reemerg
viral
agent
field
antivir
compound
discoveri
promis
emerg
reemerg
virus
consid
continu
threat
human
health
amaz
abil
adapt
current
host
switch
new
host
evolv
strategi
escap
antivir
measur
virus
emerg
chang
host
environ
vector
new
pathogen
virus
aris
human
exist
human
virus
anim
virus
sever
viral
diseas
emerg
last
decad
becom
entrench
human
popul
worldwid
best
known
exampl
sar
coronaviru
west
nile
viru
monkey
pox
viru
hantaviru
nipah
viru
hendraviru
chikungunya
viru
last
least
threat
pandem
influenza
virus
recent
avian
swine
origin
unfortun
methodolog
advanc
led
detect
match
equal
advanc
abil
prevent
control
diseas
improv
antivir
therapi
wide
margin
ineffect
therefor
new
antivir
agent
urgent
need
continu
battl
invad
virus
host
respons
technolog
advanc
led
discoveri
character
molecul
requir
viral
replic
develop
antivir
agent
inhibit
virus
inde
provid
extraordinari
genet
adapt
enabl
escap
antivir
inhibit
certain
case
regain
advantag
host
mutagenesi
creat
new
viral
strain
acquir
resist
antivir
compound
avail
cours
viral
infect
govern
complex
interact
viru
host
cellular
system
virus
depend
upon
host
cell
protein
synthesi
thu
virus
replic
via
broadli
similar
sequenc
event
figur
viru
must
first
bind
cell
viru
genom
enter
cytoplasm
genom
liber
protect
capsid
either
nucleu
cytoplasm
transcrib
viral
mrna
direct
protein
synthesi
gener
well
regul
fashion
final
viru
undergo
genom
replic
togeth
viral
structur
protein
assembl
new
virion
releas
cell
singl
describ
phase
repres
possibl
target
inhibit
drug
target
viral
attach
entranc
prove
difficult
discov
fact
date
one
entri
inhibitor
approv
us
food
drug
administr
fda
enfuvirtid
synthet
peptid
target
hiv
envelop
protein
prevent
fusion
target
earli
step
viru
entri
attract
strategi
therapeut
intervent
sinc
site
action
inhibitor
like
extracellular
therefor
rel
access
could
pair
concomit
action
drug
multipl
target
obtain
effect
therapeut
compound
moreov
one
could
expect
futur
antivir
agent
broadspectrum
action
virus
differ
famili
use
first
aid
compound
unforeseen
viral
epidem
pandem
due
outbreak
emerg
infecti
diseas
caus
differ
pathogen
virus
develop
antivir
resist
classic
antivir
drug
pharmaceut
compani
numer
research
seek
new
antivir
agent
present
scenario
nanoscal
materi
emerg
novel
antimicrobi
agent
due
high
surfac
area
volum
ratio
uniqu
chemic
physic
properti
nanotechnolog
emerg
field
appli
scienc
cut
edg
technolog
util
physicochem
properti
nanomateri
mean
control
size
surfac
area
shape
order
gener
differ
nanoscales
materi
among
materi
metalbas
one
seem
interest
promis
repres
subject
present
review
nanotechnolog
directli
link
physic
chemistri
biolog
materi
scienc
medicin
fact
find
applic
multipl
aspect
research
everyday
life
electron
new
materi
design
howev
use
medic
research
probabl
one
fastest
grow
area
function
mechan
nanoparticl
especi
metalbas
nanoparticl
begin
exploit
nanotechnolog
use
develop
nanoparticlebas
target
drug
carrier
rapid
pathogen
detect
biomolecular
sens
well
nanoparticlebas
cancer
therapi
use
nanoparticl
extend
develop
antivir
act
interf
viral
infect
particularli
attach
entri
nanoparticl
properli
defin
particl
least
one
dimens
less
nm
attract
much
attent
uniqu
interest
properti
singular
physic
eg
plasmon
reson
fluoresc
enhanc
chemic
eg
catalyt
activ
enhanc
properti
deriv
high
quantiti
surfac
atom
high
areavolum
relat
fact
diamet
decreas
avail
surfac
area
particl
increas
dramat
consequ
increas
origin
properti
bulk
materi
consid
biolog
interact
gener
multival
interplay
microb
host
cell
often
involv
multipl
copi
receptor
ligand
bind
coordin
manner
result
enhanc
specif
effici
strength
interact
allow
microbi
agent
take
possess
cell
attack
attach
entri
virus
host
cell
repres
terrif
exampl
multival
interact
viral
surfac
compon
cell
membran
receptor
interf
recognit
event
therebi
block
viral
entri
cell
one
promis
strategi
pursu
develop
new
antivir
drug
prevent
topic
microbicid
recent
year
use
metal
nanoparticl
may
function
surfac
optimis
interact
see
increas
success
idea
exploit
metal
microorgan
consid
ancient
fact
use
silver
common
expedi
cook
procedur
preserv
water
contamin
import
silver
cur
properti
known
centuri
fact
silver
extens
studi
metal
purpos
fight
infect
prevent
food
spoilag
notwithstand
declin
use
consequ
develop
antibiot
prophylaxi
gonococc
ophthalmia
neonatorum
silver
ion
consid
standard
care
mani
countri
end
centuri
silver
mode
action
presum
depend
ag
ion
strongli
inhibit
bacteri
growth
suppress
respiratori
enzym
electron
transport
compon
interfer
dna
function
therefor
antibacteri
antifung
antivir
properti
silver
ion
silver
compound
extens
studi
silver
also
found
nontox
human
small
concentr
microorgan
unlik
develop
resist
silver
compar
antibiot
silver
attack
broad
rang
target
microb
consid
broad
literatur
describ
silver
bulk
materi
effect
wide
rang
pathogen
silver
nanoparticl
analys
found
extrem
appeal
silver
nanoparticl
also
found
divers
applic
form
wound
dress
coat
medic
devic
silver
nanoparticl
impregn
textil
fabric
advantag
use
silver
nanoparticl
impregn
continu
releas
silver
ion
enhanc
antimicrobi
efficaci
burn
wound
treat
silver
nanoparticl
show
better
cosmet
appear
scarless
heal
silver
nanoparticl
receiv
consider
attent
antimicrobi
agent
shown
effect
mainli
antibacteri
antimicrobi
effect
shown
gramposit
gramneg
bacteria
antibacteri
activ
silver
nanoparticl
mainli
demonstr
vitro
experi
activ
methicillinresist
staphylococcu
aureu
mrsa
escherichia
coli
pseudomona
aeruginosa
vibrio
cholera
bacillu
subtili
document
low
concentr
silver
nanoparticl
abl
consist
inhibit
e
coli
growthinhibitori
effect
aureu
minor
synergist
antimicrobi
activ
silver
zinc
nanoparticl
ampicillin
penicillin
g
amoxicillin
kanamycin
erythromycin
clindamycin
chloramphenicol
vancomycin
aureu
e
coli
salmonella
typhi
micrococcu
luteu
observ
also
gold
nanoparticl
exploit
antimicrobi
agent
mainli
tool
deliv
antimicrobi
order
enhanc
photodynam
kill
bacteria
mani
studi
shown
antimicrobi
effect
metal
nanoparticl
effect
silver
nanoparticl
fungal
pathogen
mostli
unknown
silver
nanoparticl
inde
show
signific
antifung
activ
penicillium
citrinum
aspergillu
niger
trichophyton
mentagrophyt
candida
albican
differ
type
nanomateri
like
copper
zinc
titanium
magnesium
gold
algin
silver
come
recent
year
proven
effect
divers
microorgan
present
review
aim
descript
report
antivir
activ
metal
nanoparticl
product
method
particular
regard
silver
nanoparticl
metal
nanoparticl
studi
antimicrobi
potenti
proven
antibacteri
agent
gramneg
gramposit
bacteria
theoret
metal
could
analys
antivir
activ
howev
littl
effort
done
determin
interact
metal
nanoparticl
virus
recent
studi
emerg
show
metal
nanoparticl
effect
antivir
agent
hepat
b
viru
respiratori
syncyti
viru
herp
simplex
viru
type
monkeypox
viru
influenza
viru
tacarib
viru
seen
pauciti
virus
investig
fact
nanoparticl
use
made
silver
section
instrument
analys
inhibitori
effect
singl
viru
tabl
acquir
immunodefici
syndrom
aid
diseas
caus
hiv
respons
two
million
death
per
year
among
million
peopl
infect
highli
activ
antiretrovir
therapi
haart
treatment
regimen
employ
cocktail
drug
suppress
hiv
infect
significantli
improv
qualiti
life
life
expect
million
hivinfect
individu
numer
hivinfect
individu
current
treat
haart
individu
harbor
chronic
longterm
infect
result
hiv
eventu
develop
resist
drug
result
need
chang
medic
regimen
subsequ
increas
cost
treatment
replic
cycl
complex
multistep
process
depend
viral
host
cell
factor
entri
target
cell
achiev
fusion
viral
lipid
envelop
cellular
plasma
membran
viral
compon
act
fulcrum
mediat
fusion
trimer
envelop
glycoprotein
compos
two
subunit
bind
cellular
receptor
subunit
bear
transmembran
segment
execut
fusion
follow
bind
cellular
receptor
subsequ
interact
coreceptor
conform
chang
lead
membran
fusion
deliveri
capsid
cytoplasm
soon
entri
rna
reversetranscrib
complementari
dna
convert
doublestrand
dna
integr
cellular
genom
integr
provir
dna
transcrib
gener
fulllength
progeni
viral
rna
number
splice
mrna
transcript
transcript
translat
perform
cellular
machineri
result
synthesi
viral
protein
togeth
progeni
viral
rna
transport
site
viru
particl
assembl
plasma
membran
viru
gain
access
extracellular
milieu
upon
bud
event
elechiguerra
et
al
first
describ
antivir
activ
metal
nanoparticl
fact
found
silver
nanoparticl
undergo
sizedepend
interact
investig
explor
possibl
physicochem
properti
nanoparticl
may
depend
nanoparticl
interact
cap
agent
molecul
reason
test
silver
nanoparticl
three
differ
surfac
chemistri
foami
carbon
poli
pvp
bovin
serum
albumin
bsa
foami
carbonco
silver
nanoparticl
embed
foami
carbon
matrix
need
preclud
coalesc
synthesi
pvpcoat
nanoparticl
synthes
use
glycerin
reduc
agent
solvent
method
metal
precursor
dissolv
liquid
polyol
presenc
cap
agent
pvp
synthesi
aqueou
solut
perform
bsaconjug
silver
nanoparticl
interact
silver
nanoparticl
probe
aid
high
angl
annular
dark
field
haadf
scan
transmiss
electron
microscopi
technolog
possibl
obtain
suffici
data
determin
interact
hiv
particl
silver
nanoparticl
clearli
due
size
silver
nanoparticl
sinc
nanoparticl
within
rang
nm
abl
bind
viru
particular
nanoparticl
randomli
attach
viru
three
speci
nanoparticl
establish
regular
spatial
relationship
viral
envelop
probabl
site
interact
found
sulfurbear
residu
glycoprotein
knob
limit
number
may
also
explain
inabl
larger
nanoparticl
bind
viru
capac
silver
nanoparticl
inhibit
infect
laboratoryadapt
strain
noncytotox
concentr
determin
vitro
assay
dosedepend
inhibit
viral
infect
report
particular
bsaand
pvpcoat
nanoparticl
show
possess
slightli
lower
inhibit
efficaci
probabl
surfac
nanoparticl
directli
bound
encapsul
cap
agent
contrast
silver
nanoparticl
releas
carbon
matrix
greater
inhibitori
effect
due
essenti
free
surfac
area
find
howev
provid
indirect
evid
propos
mode
interact
bind
therefor
panel
differ
vitro
assay
use
elucid
silver
nanoparticl
mode
antivir
action
luciferasebas
assay
show
silver
nanoparticl
coat
pvp
effect
virucid
agent
cellfre
viru
includ
laboratori
strain
clinic
isol
tropic
strain
resist
strain
cellassoci
viru
concentr
silver
nanoparticl
infect
inhibit
rang
mgml
observ
antivir
effect
silver
nanoparticl
due
nanoparticl
rather
silver
ion
present
solut
fact
silver
salt
exert
antibacteri
effect
silver
ion
inhibit
therapeut
index
time
lower
one
silver
nanoparticl
silver
nanoparticl
inhibit
initi
stage
infect
cycl
block
adsorpt
infect
cellfus
assay
inhibitori
activ
silver
nanoparticl
interact
also
investig
competit
elisa
togeth
cellbas
fusion
assay
show
silver
nanoparticl
inhibit
infect
block
viral
entri
particularli
interact
besid
silver
nanoparticl
inhibit
postentri
stage
life
cycl
fact
antivir
activ
maintain
also
metal
nanoparticl
ad
h
cell
infect
hiv
sinc
silver
ion
form
complex
electron
donor
group
contain
sulfur
oxygen
nitrogen
normal
present
thiol
phosphat
amino
acid
nucleic
acid
might
inhibit
postentri
stage
infect
block
protein
reduc
revers
transcript
provir
transcript
rate
directli
bind
rna
dna
molecul
silver
nanoparticl
prove
virucid
cellfre
cellassoci
judg
viral
infect
assay
hiv
infect
effect
elimin
follow
short
exposur
isol
viru
silver
nanoparticl
properti
make
silver
nanoparticl
potenti
broadspectrum
agent
prone
induc
resist
could
use
prevent
wide
varieti
circul
strain
pvpcoat
silver
nanoparticl
interest
virucid
candid
drug
investig
potenti
topic
vagin
microbicid
prevent
transmiss
infect
use
vitro
human
cervic
tissuebas
organ
cultur
simul
vivo
condit
formul
nonspermicid
gel
replen
concentr
mgml
pvpcoat
silver
nanoparticl
toxic
explant
even
cervic
tissu
expos
continu
metal
hour
one
minut
pretreat
cervic
explant
mgml
pvpcoat
silver
nanoparticl
prevent
transmiss
cellassoci
cellfre
isol
pretreat
carri
minut
follow
extens
wash
drug
confer
almost
total
protect
transmiss
hour
indic
longlast
protect
effect
pvpcoat
silver
nanoparticl
cervic
explant
differ
group
also
report
antivir
activ
silver
nanoparticl
fabric
use
hepe
buffer
show
silver
nanoparticl
exhibit
potent
cytoprotect
postinfect
activ
mm
reduct
achiev
toward
cell
dosedepend
fashion
similar
inhibitori
activ
report
silver
nanoparticl
citrat
solut
nabh
reduc
agent
use
lower
activ
observ
gold
nanoparticl
nm
fabric
hepe
buffer
herpesviru
famili
consist
doublestrand
dna
virus
divid
subgroup
eight
herpesvirus
known
commonli
infect
human
remaind
anim
herpesvirus
infect
wide
varieti
anim
speci
member
herpesviru
famili
caus
lifelong
latent
infect
structur
linear
doublestrand
dna
genom
packag
icosahedr
capsid
cover
lipid
envelop
embed
protein
glycoprotein
symptomat
diseas
caus
prototyp
gener
limit
cold
sore
mouth
kerat
eye
capabl
caus
lifethreaten
diseas
immunocompromis
individu
includ
newborn
patient
hiv
patient
undergo
immunosuppress
treatment
transmiss
among
human
requir
physic
contact
initi
infect
viru
remain
latent
neuron
key
featur
hsv
entri
host
cell
mark
first
possibl
critic
step
viral
pathogenesi
five
viral
glycoprotein
implic
viral
entri
process
gb
gc
gd
gh
gl
gc
essenti
entri
initi
interact
bind
cell
mediat
via
interact
gc
andor
gb
heparan
sulfat
hs
signific
reduct
infect
absenc
either
viral
gc
cellsurfac
hs
point
key
role
gc
highaffin
bind
heparan
sulfat
hs
cell
surfac
follow
bind
hsv
entri
achiev
fusion
lipid
bilay
viral
envelop
host
cell
membran
core
fusion
machineri
compos
gb
ghgl
fact
complet
fusion
achiev
three
protein
act
togeth
glycoprotein
b
may
act
premier
fusogen
seem
need
cooper
sever
membranotrop
sequenc
harbour
gh
transcript
replic
viral
dna
assembl
progeni
capsid
take
place
within
host
nucleu
complex
mechan
exit
newli
assembl
virus
cell
barampinto
et
al
describ
two
consecut
work
potenti
exploit
metal
nanoparticl
viral
inhibit
strategi
prove
valid
probabl
intend
may
prove
use
virus
papillomavirus
hpv
hiv
fact
agent
base
principl
mimic
hs
may
compet
bind
viru
cell
also
hiv
hpv
use
hs
dock
site
infect
therefor
nanoparticl
describ
barampinto
et
al
may
use
broad
topic
microbicid
sexuallytransmit
viral
infect
anoth
point
particular
interest
work
analysi
signific
carrier
core
materi
fact
design
two
differ
metal
particl
one
made
silver
made
gold
coat
mercaptoethan
sulfon
me
intend
mimic
polysulfon
hs
therefor
expect
creat
high
local
concentr
bind
molecul
improv
inhibitori
effect
silver
agm
gold
aum
me
nanoparticl
test
antivir
assay
use
wildtyp
mcintyr
strain
inhibit
experi
vero
cell
andor
viru
solut
treat
agm
aum
nanoparticl
differ
time
point
analys
differ
stage
viral
infect
may
block
taken
togeth
result
indic
sulfonatecap
silver
gold
nanoparticl
inhibit
infect
block
attach
therebi
entranc
viru
cell
andor
prevent
celltocel
spread
viru
inabl
solubl
me
unmodifi
metal
nanoparticl
control
viral
infect
stress
import
spatial
orient
function
group
anchor
nanoparticl
core
viral
inhibit
time
antivir
activ
shown
agm
aum
nanoparticl
suggest
possibl
use
altern
carrier
core
materi
well
result
suggest
versatil
idea
effect
viral
inhibit
use
function
nanoparticl
also
indic
core
materi
could
also
effici
long
toxic
host
cell
respiratori
syncyti
viru
rsv
belong
famili
paramyxovirida
infect
epithelium
lung
respiratori
tract
caus
seriou
respiratori
diseas
especi
children
older
peopl
vaccin
adequ
pharmaceut
compound
avail
underlin
need
develop
futur
rsv
treatment
rsv
genom
consist
singl
rna
molecul
negativesens
rna
encod
among
other
two
surfac
glycoprotein
expos
viral
envelop
glycoprotein
g
protein
serv
receptor
bind
protein
f
protein
respons
fusion
cell
membran
viral
envelop
within
name
viru
follow
infect
cell
f
protein
express
surfac
cell
fuse
adjac
cell
give
rise
syncytia
format
well
characteris
cytopath
effect
sun
et
al
util
silver
nanoparticl
conjug
variou
protein
studi
inhibit
rsv
infect
cell
cultur
studi
cap
agent
use
silver
nanoparticl
poli
pvp
bovin
serum
albumin
bsa
recombin
f
protein
rsv
rf
preliminari
analysi
transmiss
electron
microscopi
yield
interest
result
interact
silver
nanoparticl
rsv
virion
particl
bsaconjug
silver
nanoparticl
seem
interact
rsv
without
specif
associ
spatial
arrang
rf
silver
nanoparticl
appear
float
freeli
proof
regular
attach
hand
pvpcoat
silver
nanoparticl
abl
bind
viral
surfac
regular
spatial
arrang
suggest
possibl
interact
g
protein
evenli
distribut
envelop
rsv
virion
hypothesis
interpret
interact
pvpnanoparticl
g
protein
small
size
uniform
nm
compar
bsa
rf
coat
nanoparticl
nm
may
contribut
effect
bind
sinc
toxic
imper
issu
regard
pharmaceut
compound
cytotox
nanoparticl
conjug
establish
use
trypan
blue
exclus
assay
reveal
bsa
pvpand
rf
nanoparticl
show
less
cytotox
concentr
silver
nanoparticl
regard
potenti
harm
especi
intend
treat
respiratori
diseas
rsv
infect
sun
et
al
therefor
consid
satur
surfac
cap
compos
natur
biomolecul
bsa
biocompat
chemic
pvp
could
abl
mask
pure
nanosilv
surfac
thu
would
reduc
toxic
without
hamper
efficaci
nevertheless
studi
need
valid
vitro
data
use
clinic
set
investig
toxic
effect
fate
nanoparticl
deposit
respiratori
tract
mandatori
futur
develop
antirsv
silver
nanoparticlesbas
therapeut
compound
cell
infect
rsv
mix
bsa
pvpand
rf
silver
nanoparticl
infect
inhibit
evalu
microscop
examin
syncytia
format
immunofluoresc
microscopi
neither
bsanor
rf
nanoparticl
show
signific
inhibit
rsv
infect
pvpcoat
silver
nanoparticl
inhibit
rsv
infect
result
led
author
conclud
silver
nanoparticl
conjug
pvp
protein
mix
rsv
bind
g
protein
viral
surfac
interfer
viral
attach
cell
result
inhibit
viral
infect
hepat
b
viru
hbv
partial
doublestrand
dna
viru
provid
lipid
envelop
coat
hbv
strong
tropism
hepatocyt
enter
cell
viral
particl
migrat
nucleu
viral
genom
complet
form
coval
close
circular
dna
cccdna
serv
templat
subsequ
step
viral
mrna
transcript
format
pregenom
rna
pgrna
pgrna
form
templat
reserv
transcript
viralencod
reversetranscriptas
produc
new
viral
genom
nucleotid
adefovir
nucleosid
lamivudin
entecavir
telbivudin
analogu
inhibitor
repres
approv
pharmaceut
direct
antivir
activ
hbv
target
primarili
viral
polymeras
reversetranscriptas
although
effect
proven
rais
drugresist
hbv
strain
fast
therefor
limit
use
antivir
lu
et
al
analys
monodispers
silver
nanoparticl
abil
inhibit
hbv
replic
nanoparticl
use
studi
prepar
agno
hepe
measur
dimens
nm
nm
nm
silver
nanoparticl
particl
diamet
nm
toxic
evalu
antivir
compound
nm
nm
particl
show
minor
toxic
concentr
abl
inhibit
hbv
replic
fact
nanoparticl
size
show
potent
antihbv
activ
reach
inhibit
slightli
activ
concentr
respect
paper
lu
et
al
activ
silver
nanoparticl
also
compar
nm
gold
nanoparticl
silver
compound
silver
differ
oxid
state
overal
result
show
antihbv
effect
silver
nanoparticl
undoubtedli
much
pronounc
conclus
silver
nanoparticl
abl
inhibit
product
hbv
rna
extracellular
virion
probabl
via
specif
interact
nanoparticl
doublestrand
dna
hbv
andor
direct
bind
viral
particl
influenza
viru
highli
contagi
pathogen
caus
annual
epidem
human
popul
much
fear
potenti
gener
new
virus
abl
jump
human
differ
anim
speci
caus
pandem
recent
papp
et
al
describ
studi
function
gold
nanoparticl
use
inhibit
influenza
viru
orthomyxoviru
contain
helic
capsid
genom
eight
rna
segment
capsid
cover
lipid
envelop
contain
mainli
two
virallyencod
glycoprotein
name
hemoagglutinin
ha
neuraminidas
na
form
spiki
project
surfac
viru
bind
cell
plasma
membran
interact
ha
sialic
acid
sa
residu
present
glycoprotein
lipid
surfac
host
cell
soon
follow
mechan
receptormedi
endocytosi
bring
envelop
viru
particl
insid
cytoplasm
surround
second
lipid
bilay
besid
envelop
endosom
one
insid
late
endosom
environ
acidif
trigger
conform
chang
ha
set
motion
mechan
protein
ha
mediat
fusion
endosom
membran
viral
envelop
end
releas
nucleoprotein
genom
fragment
cytoplasm
papp
et
al
strategi
function
gold
nanoparticl
sialic
acid
sa
termin
glycerol
dendron
object
inhibit
influenza
viru
bind
plasma
membran
gold
nanoparticl
differ
size
produc
one
nm
second
nm
found
nm
inhibitori
effect
hemagglutin
use
test
abil
influenza
viru
bind
target
membran
contrari
nm
gold
nanoparticl
inhibit
hemagglutin
concentr
nanomolar
rang
demonstr
activ
clearli
depend
particl
dimens
spatial
distribut
interact
ligandreceptor
molecul
trend
pronounc
activ
observ
influenza
viru
inhibit
assay
sialyl
particl
nm
size
found
effect
influenza
viru
inhibit
wherea
nm
analogu
show
signific
impact
therefor
prove
sialicacidfunction
gold
nanoparticl
abl
effect
inhibit
viral
infect
monkeypox
viru
mpv
orthopoxviru
similar
variola
viru
caus
agent
monkeypox
mani
speci
nonhuman
primat
also
human
pathogen
clinic
present
similar
smallpox
mpv
consid
big
threat
human
life
therefor
research
carri
develop
drug
therapeut
agent
viru
differ
size
nanoparticl
produc
plasma
ga
synthesi
use
roger
et
al
plaqu
reduct
assay
mpv
silver
nanoparticl
use
work
nm
nanoparticl
also
coat
polysaccharid
nm
nanoparticl
nanoparticl
concentr
rang
evalu
mpv
inhibitori
efficaci
use
plaqu
reduct
assay
main
result
show
polysaccharideco
nm
noncoat
nm
exert
signific
dosedepend
inhibit
mpv
plaqu
format
mechan
inhibit
occur
investig
poxvirus
enter
cell
endocytosi
direct
fusion
plasma
membran
least
envelop
protein
involv
entri
mechan
follow
regul
sequenc
event
allow
viru
replic
mani
step
viru
life
cycl
still
unknown
report
activ
silver
nanoparticl
preliminari
attempt
give
satisfactori
explan
mechan
action
probabl
silver
nanoparticl
may
interven
earli
step
bind
penetr
block
virushost
cell
bind
physic
obstruct
internalis
disrupt
intracellular
pathway
import
viru
replic
roger
et
al
also
describ
agno
activ
mpv
inhibitor
concentr
toxic
effect
vero
cell
imped
evalu
antivir
activ
interestingli
nanoparticl
analys
studi
promot
increas
mean
number
mpv
plaqueswel
highest
concentr
use
potenti
explan
contrast
result
could
lie
fact
nanoparticl
may
tend
aggreg
consequ
creat
cell
area
avail
increas
contact
viral
particl
cell
membran
therefor
augment
intern
plaqu
format
howev
data
preliminari
need
indepth
analysi
draw
signific
conclus
famili
arenavirida
compos
differ
speci
virus
divid
two
antigen
group
old
world
new
world
tacarib
complex
group
tacarib
complex
addit
tacarib
viru
tcrv
includ
viral
hemorrhag
feverinduc
virus
junin
machupo
guanarito
sabia
consid
high
transmiss
persontoperson
via
respiratori
rout
lack
diagnost
test
therapeut
option
limit
ribavirin
satisfactori
efficaci
easili
emerg
resist
strain
arenavirus
includ
categori
list
potenti
bioweapon
tcrv
human
pathogen
exhibit
close
antigen
relationship
junin
guanarito
virus
therefor
could
serv
well
model
viru
arenaviru
deriv
diseas
without
human
pathogen
potenti
adequ
safeti
laboratori
manipul
speshock
et
al
recent
analys
activ
two
type
silver
nanoparticl
tcrv
uncoat
agnp
polysaccharid
coat
silver
nanoparticl
psag
found
tcrv
treat
even
nm
agnp
signific
reduct
progeni
viru
titer
detect
progeni
viru
produc
psag
particl
show
similar
trend
effect
toxic
reduc
therefor
polysaccharid
coat
may
inde
protect
cell
toxic
effect
agnp
also
appear
interfer
agnp
interact
tcrv
silver
nanoparticl
seem
interact
tcrv
prior
cellular
exposur
result
decreas
viral
infect
nm
agnp
therefor
author
suggest
silver
nanoparticl
may
bind
virallyencod
membran
glycoprotein
fact
tcrv
glycoprotein
rich
cystein
residu
silver
nanoparticl
shown
bind
easili
thiol
group
found
cystein
residu
interact
either
prevent
intern
viral
particl
interf
cellular
receptor
bind
may
favour
intern
silver
nanoparticl
togeth
viru
produc
inhibitori
effect
viral
replic
interf
tcrv
rnadepend
rna
polymeras
l
protein
possibl
mechan
action
could
relat
fact
silver
nanoparticl
bound
viral
glycoprotein
may
prevent
viru
uncoat
endosom
final
speshock
et
al
prove
pretreat
cell
silver
nanoparticl
effect
viral
replic
therefor
conclud
agnp
could
inactiv
viru
prior
entri
cell
remov
virus
water
environ
gener
paramount
import
health
safeti
mainten
modern
societi
profoundli
reli
water
safeti
drink
leisur
activ
pathogen
virus
adenoviru
noroviru
rotaviru
hepat
commonli
occur
surfac
groundwat
sourc
must
effect
inactiv
provid
safe
water
titanium
dioxid
attract
much
attent
photocatalyst
water
treatment
resist
corros
nontox
ingest
antibacteri
properti
tio
well
document
attribut
gener
ro
especi
hydroxyl
free
radic
hydrogen
peroxid
studi
investig
antivir
properti
tio
potenti
inactiv
virus
demonstr
howev
inactiv
rate
obtain
studi
extrem
low
exampl
cho
et
al
demonstr
minor
remov
bacteriophag
h
irradi
use
tio
suspend
gl
inactiv
kinet
need
greatli
improv
order
provid
effici
drink
water
disinfect
liga
et
al
hypothes
possibl
synerg
mechan
occur
silver
tio
silver
dope
titanium
dioxid
use
inactiv
microorgan
uv
radiat
therefor
demonstr
silver
dope
tio
greatli
enhanc
photocatalyt
inactiv
virus
primarili
increas
hydroxyl
free
radic
product
addit
slightli
increas
viru
adsorpt
silver
dope
significantli
enhanc
inactiv
tio
inactiv
rate
increas
silver
content
silver
dope
tio
nanoparticl
consider
remov
could
obtain
second
render
feasibl
goal
achiev
viru
remov
drink
water
use
photoreactor
exploit
metal
nanoparticl
although
continu
evolut
field
metalbas
nanoparticl
drug
deliveri
medic
imag
diagnost
therapeut
engin
technolog
seriou
lack
inform
impact
metal
nanoparticl
human
health
environ
probabl
due
intrins
complex
natur
nanoparticl
led
differ
attitud
safeti
therefor
import
issu
use
metal
nanoparticl
potenti
toxic
metal
nanoparticl
effect
antivir
pharmaceut
imper
gain
better
understand
biodistributionaccumul
live
system
princip
characterist
metal
nanoparticl
size
fall
individu
atom
molecul
correspond
bulk
materi
particl
size
surfac
area
modifi
physicochem
properti
metal
materi
also
influenc
reactiv
nanoparticl
cellular
environ
lead
differ
mode
cellular
uptak
process
lead
advers
biolog
effect
live
cell
would
otherwis
possibl
materi
larger
form
fact
particl
size
decreas
metal
nanoparticl
show
increas
toxic
even
materi
rel
inert
bulk
form
eg
ag
au
cu
apart
size
biolog
consequ
metal
nanoparticl
also
depend
chemic
composit
surfac
structur
solubl
shape
aggreg
paramet
modifi
cellular
uptak
protein
bind
transloc
target
site
biolog
interact
possibl
caus
tissu
injuri
therefor
term
safeti
effect
silver
nanoparticl
major
consider
even
inhibit
viral
infect
would
benefici
advers
effect
human
anim
commonli
use
strategi
reduc
possibl
toxic
use
variou
cap
agent
prevent
direct
contact
metal
cell
potenti
rout
human
exposur
metal
nanoparticl
use
therapeut
compound
includ
gastrointestin
tract
skin
lung
system
administr
consid
use
metal
nanoparticl
point
view
potenti
antivir
therapi
straightforward
safest
easiest
result
obtain
topic
use
nanoparticl
microbicid
direct
viral
particl
inactiv
andor
inhibit
earli
step
viral
life
cycl
attach
entri
therefor
dermal
rout
seem
one
major
concern
dermal
exposur
metal
nanoparticl
often
take
place
use
sunscreen
lotion
exampl
tio
zno
nanoparticl
healthi
skin
epidermi
provid
excel
protect
particl
spread
dermi
howev
presenc
damag
skin
micrometers
particl
gain
access
dermi
region
lymph
node
concern
potenti
nanoparticl
transloc
brain
via
olfactori
nerv
consequ
vicin
nasal
mucosa
olfactori
bulb
whether
nanoparticl
tissu
patholog
clinic
signific
uncertain
therefor
data
need
properli
address
safeti
concern
use
metal
nanoparticl
pharmaceut
sever
studi
demonstr
cytotox
effect
metal
nanoparticl
fact
silver
nanoparticl
found
highli
cytotox
mammalian
cell
base
assess
mitochondri
function
membran
leakag
lactat
dehydrogenas
abnorm
cell
morpholog
cellular
level
metal
nanoparticl
interact
biolog
molecul
within
mammalian
cell
interfer
antioxid
defenc
mechan
lead
gener
reactiv
oxygen
speci
ro
speci
excess
caus
damag
biolog
compon
oxid
lipid
protein
dna
oxid
stress
may
role
induct
enhanc
inflamm
upregul
redox
sensit
transcript
factor
eg
activ
kinas
involv
inflamm
gener
reactiv
oxygen
speci
cell
expos
silver
nanoparticl
show
human
lung
fibroblast
human
glioblastoma
cell
consequ
dna
damag
cell
cycl
abnorm
observ
accumul
silver
nanoparticl
variou
organ
lung
kidney
brain
liver
test
evidenc
anim
studi
vitro
studi
show
dose
depend
fact
higher
dose
silver
induc
strongher
cellular
toxic
nevertheless
consid
vitro
concentr
nanoparticl
often
much
higher
one
use
vivo
experi
therefor
exposur
repres
replica
condit
expect
vivo
exposur
recent
studi
show
mice
expos
silver
nanoparticl
show
minim
pulmonari
inflamm
cytotox
follow
subacut
exposur
longer
term
exposur
higher
lung
burden
nanosilv
investig
therefor
eventu
cronic
effect
may
underscor
review
present
brief
descript
toxic
deriv
use
metal
nanoparticl
detail
coverag
topic
avail
recent
publish
review
although
signific
progress
made
elucid
mechan
silver
nanomateri
toxic
prove
consensu
immedi
impact
long
term
effect
human
health
still
miss
research
requir
provid
necessari
warranti
allow
safe
exploit
interest
vitro
antivir
properti
silver
nanoparticl
transfer
clinic
set
nanoparticl
nanoscal
cluster
metal
atom
engin
practic
purpos
typic
antimicrobi
steril
applic
differ
wet
chemic
method
use
synthesi
metal
nanoparticl
dispers
earli
method
produc
nanoparticl
noblemet
still
use
today
continu
standard
synthesi
method
compar
common
method
involv
use
excess
reduc
agent
sodium
citrat
nabh
ayyanppan
et
al
obtain
ag
au
pd
cu
nanoparticl
reduc
metal
salt
dri
ethanol
longenberg
et
al
produc
au
ag
pd
metal
colloid
airsatur
aqueou
solut
poli
ethylen
glycol
peg
reduct
method
also
use
product
pt
pd
cu
mi
etc
although
specif
protocol
depend
reduct
potenti
sourc
ion
cu
ni
stabl
metal
particl
easili
oxid
requir
strong
cap
ligand
prevent
oxid
initi
reduct
variou
complex
metal
ion
lead
format
atom
follow
agglomer
oligomer
cluster
control
synthesi
usual
base
twostep
reduct
process
first
step
strong
reduc
agent
use
produc
small
particl
second
step
small
particl
enlarg
reduct
weaker
reduc
agent
strong
reduct
lead
small
monodispers
particl
gener
larger
size
particl
difficult
control
weaker
reduct
produc
slower
reduct
reaction
nanoparticl
obtain
tend
polydispers
size
differ
studi
report
enlarg
particl
secondari
step
nm
nm
anoth
gener
method
product
differ
metal
nanoparticl
au
ag
pt
pd
use
commonli
avail
sugar
eg
glucos
fructos
sucros
reduc
agent
approach
sever
import
featur
sugar
glucos
fructos
sucros
easili
avail
use
reduc
agent
upon
exploit
stabil
agent
cap
agent
requir
stabil
nanoparticl
sugar
cheap
biofriendli
nanoparticl
safe
preserv
essicc
month
redispers
aqueou
solut
whenev
requir
instead
kept
aqueou
solut
array
physic
chemic
method
use
produc
nanomateri
order
synthes
nobl
metal
nanoparticl
particular
shape
size
specif
methodolog
formul
ultraviolet
irradi
aerosol
technolog
lithographi
laser
ablat
ultrason
field
photochem
reduct
techniqu
although
remain
expens
involv
use
hazard
chemic
therefor
grow
concern
develop
environmentfriendli
sustain
method
biosynthesi
gold
silver
goldsilv
alloy
selenium
tellurium
platinum
palladium
silica
titania
zirconia
quantum
dot
magnetit
uraninit
nanoparticl
bacteria
actinomycet
fungi
yeast
virus
report
howev
despit
stabil
biolog
nanoparticl
monodispers
rate
synthesi
slow
overcom
problem
sever
factor
microbi
cultiv
method
extract
techniqu
optim
factor
shape
size
natur
control
modifi
ph
temperatur
nutrient
media
composit
owe
rich
biodivers
microb
potenti
biolog
materi
nanoparticl
synthesi
yet
fulli
explor
product
metal
nanoparticl
involv
three
main
step
includ
select
solvent
medium
select
environment
benign
reduc
agent
select
nontox
substanc
nanoparticl
stabil
biominer
also
attract
techniqu
best
natur
friendli
method
nanoparticl
synthesi
one
biomimet
approach
toward
gener
nanocryst
silver
reduct
silver
ion
carri
use
bacteria
unicellular
organ
reduct
mediat
mean
enzym
presenc
enzym
organ
found
respons
synthesi
therefor
search
methodolog
could
provid
safer
easier
synthesi
metal
nanoparticl
seem
biogen
synthesi
use
filtrat
supernat
differ
bacteri
fungal
cultur
consider
impact
reduct
metal
ion
occur
releas
reductas
enzym
solut
extens
coverag
biolog
synthesi
metal
nanoparticl
microb
refer
recent
review
narayanan
sakthivel
crusad
toward
develop
drug
therapi
viral
diseas
emerg
resist
viral
strain
advers
side
effect
associ
prolong
use
repres
huge
obstacl
difficult
circumv
therefor
multidisciplinari
research
effort
integr
classic
epidemiolog
clinic
approach
crucial
develop
improv
antivir
altern
strategi
nanotechnolog
emerg
give
opportun
reexplor
biolog
properti
known
antimicrobi
compound
metal
manipul
size
metal
nanoparticl
especi
one
produc
silver
gold
proven
exhibit
virucid
activ
broadspectrum
virus
sure
reduc
viral
infect
cultur
cell
case
direct
interact
nanoparticl
viru
surfac
protein
could
demonstr
hypothes
intrigu
problem
solv
understand
exact
site
interact
modifi
nanoparticl
surfac
characterist
broader
effect
use
besid
direct
interact
viral
surfac
glycoprotein
metal
nanoparticl
may
gain
access
cell
exert
antivir
activ
interact
viral
genom
dna
rna
furthermor
intracellular
compart
infect
cell
overcrowd
viral
encod
host
cellular
factor
need
allow
viral
replic
proper
product
progeni
virion
interact
metal
nanoparticl
factor
key
effici
viral
replic
may
also
repres
mechan
action
figur
publish
literatur
describ
antivir
activ
silver
gold
nanoparticl
envelop
virus
dna
rna
genom
consid
one
main
argument
toward
efficaci
analys
nanoparticl
fact
virtu
shape
size
interact
viru
particl
welldefin
spatial
arrang
possibl
metal
nanoparticl
activ
nake
virus
seem
appeal
moreov
alreadi
proven
silver
gold
nanoparticl
may
use
core
materi
howev
report
yet
avail
use
metal
futur
hold
mani
surpris
especi
consid
cap
molecul
could
investig
virtual
unlimit
nonetheless
metal
nanoparticl
use
therapeut
prophylact
treatment
regimen
critic
understand
vivo
toxic
potenti
longterm
sequela
associ
exposur
compound
addit
research
need
determin
safe
design
use
dispos
product
contain
metal
nanomateri
without
creat
new
risk
human
environ
author
declar
conflict
interest
